Dr. Ferrer Biopharma to Showcase Groundbreaking Research in Post-COVID Treatment at ERS Congress 2023
Intranasal Chlorpheniramine Shows Significant Promise in Mitigating Prolonged Post-COVID-19 Symptoms Leading pharmaceutical research and development company Dr. Ferrer Biopharma proudly announces its participation in
United States Franck Rahaghi Ferrer Biopharma Fernando Valerio European Respiratory Society Mitigating Prolonged
Source: benzinga.com